A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation
Title:
A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation
Author:
Vincenti, Flavio Klintmalm, Goran Yang, Harold Ram Peddi, V. Blahunka, Paul Conkle, Angela Santos, Vicki Holman, John
Appeared in:
American journal of transplantation
Paging:
Volume 20 () nr. 1 pages 172-180
Year:
2020
Contents:
Publisher:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.